| Pharmacokinetic and pharmacodynamic data analysis: concepts and applications J Gabrielsson, D Weiner CRC press, 1994 | 1345* | 1994 |
| Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. B Olsson, M Johansson, J Gabrielsson, P Bolme European journal of clinical pharmacology 34 (1), 77-82, 1988 | 376 | 1988 |
| Role of variability in explaining ethanol pharmacokinetics: research and forensic applications Å Norberg, AW Jones, RG Hahn, JL Gabrielsson Clinical pharmacokinetics 42, 1-31, 2003 | 327 | 2003 |
| Non-compartmental analysis J Gabrielsson, D Weiner Computational Toxicology: Volume I, 377-389, 2012 | 295 | 2012 |
| Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamics of tolterodine N Brynne, P Dalén, G Alván, L Bertilsson, J Gabrielsson Clinical Pharmacology & Therapeutics 63 (5), 529-539, 1998 | 157 | 1998 |
| Pharmacokinetics and pharmacodynamics of tolterodine in man: a new drug for the treatment of urinary bladder overactivity. N Brynne, MM Stahl, B Hallen, PO Edlund, L Palmér, P Höglund, ... International journal of clinical pharmacology and therapeutics 35 (7), 287-295, 1997 | 139 | 1997 |
| Clinical pharmacokinetics of clozapine in chronic schizophrenic patients YF Cheng, T Lundberg, U Bondesson, L Lindström, J Gabrielsson European journal of clinical pharmacology 34, 445-449, 1988 | 112 | 1988 |
| Determination of potato glycoalkaloids and their aglycone in blood serum by high-performance liquid chromatography: Application to pharmacokinetic studies in humans KE Hellenäs, A Nyman, P Slanina, L Lööf, J Gabrielsson Journal of Chromatography B: Biomedical Sciences and Applications 573 (1), 69-78, 1992 | 111 | 1992 |
| Dynamics of target-mediated drug disposition: characteristic profiles and parameter identification LA Peletier, J Gabrielsson Journal of pharmacokinetics and pharmacodynamics 39, 429-451, 2012 | 108 | 2012 |
| Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations J Gabrielsson, H Dolgos, PG Gillberg, U Bredberg, B Benthem, G Duker Drug discovery today 14 (7-8), 358-372, 2009 | 108 | 2009 |
| Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration M Wakelkamp, G Alván, J Gabrielsson, G Paintaud Clinical Pharmacology & Therapeutics 60 (1), 75-88, 1996 | 104 | 1996 |
| Within‐and between‐subject variations in pharmacokinetic parameters of ethanol by analysis of breath, venous blood and urine Å Norberg, J Gabrielsson, AW Jones, RG Hahn British journal of clinical pharmacology 49 (5), 399-408, 2000 | 80 | 2000 |
| Modeling of dose–response–time data: four examples of estimating the turnover parameters and generating kinetic functions from response profiles J Gabrielsson, WJ Jusko, L Alari Biopharmaceutics & drug disposition 21 (2), 41-52, 2000 | 80 | 2000 |
| Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology J Gabrielsson, AR Green Journal of Pharmacology and Experimental Therapeutics 331 (3), 767-774, 2009 | 78 | 2009 |
| Analysis of methadone disposition in the pregnant rat by means of a physiological flow model JL Gabrielsson, P Johansson, U Bondesson, LK Paalzow Journal of pharmacokinetics and biopharmaceutics 13, 355-372, 1985 | 77 | 1985 |
| Accumulation and turnover of metabolites of toluene and xylene in nasal mucosa and olfactory bulb in the mouse H Ghaotous, L Dencker, J Gabrielsson, BRG Danielsson, K Bergman Pharmacology & toxicology 66 (2), 87-92, 1990 | 72 | 1990 |
| Methodology for pharmacokinetic/pharmacodynamic data analysis JL Gabrielsson, DL Weiner Pharmaceutical science & technology today 2 (6), 244-252, 1999 | 70 | 1999 |
| A physiological pharmacokinetic model for morphine disposition in the pregnant rat JL Gabrielsson, LK Paalzow Journal of Pharmacokinetics and Biopharmaceutics 11, 147-163, 1983 | 68 | 1983 |
| Time course of enzyme induction in humans: effect of pentobarbital on nortriptyline metabolism C von Bahr, E Steiner, Y Koike, J Gabrielsson Clinical Pharmacology & Therapeutics 64 (1), 18-26, 1998 | 63 | 1998 |
| MDMA: on the translation from rodent to human dosing AR Green, J Gabrielsson, CA Marsden, KCF Fone Psychopharmacology 204, 375-378, 2009 | 62 | 2009 |
